Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550913 · ClinicalTrials.gov registry record · Phase 1
Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression
A Phase 1 study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT01550913: Completed Phase 1 study, sponsored by Women and Infants Hospital of Rhode Island.
NCT01550913 is a Phase 1 study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 59 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01550913, a Phase 1 study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of Sober Network Interpersonal Psychotherapy (IPT) in treating women with depression and comorbid substance abuse.
Primary Outcome
Using the Timeline Followback, participants will report their daily use in the time period between each interview (intake, 6 weeks, 12 weeks, 18-20 weeks and 3 months post treatment). The number of heavy drinking/drug using days reported at intake will be compared to the number reported at the followup assessments.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Sober Network Interpersonal Psychotherapy (IPT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
What the finished NCT01550913 record still lists
NCT01550913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT01550913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01550913 about?
NCT01550913 is a clinical study titled "Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression". This study will evaluate the effectiveness of Sober Network Interpersonal Psychotherapy (IPT) in treating women with depression and comorbid substance abuse.
What is the current status of trial NCT01550913?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2011-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01550913?
The interventions under investigation include: Treatment as Usual (OTHER), Sober Network Interpersonal Psychotherapy (IPT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01550913?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01550913's enrollment target sits among peer trials
59 895th of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia